Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. (Q44047935)
Jump to navigation
Jump to search
scientific article published in July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. |
scientific article published in July 2002 |
Statements
1 reference
Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. (English)
1 reference
Andersen MK
1 reference
Pedersen-Bjergaard J
1 reference
Kjeldsen L
1 reference
Dufva IH
1 reference
Brøndum-Nielsen K
1 reference
1 July 2002
1 reference
Identifiers
1 reference